Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 15/20 | 0.69 |
| ▸ | PTGDR | Q13258 | 1/20 | 0.43 |
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
| ▸ | MCHR2 | Q969V1 | 1/20 | 0.38 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.38 |
| ▸ | USP25 | Q9UHP3 | 1/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | MC4R | P32245 | 1/20 | 0.37 |
| ▸ | MC5R | P33032 | 1/20 | 0.37 |
| ▸ | MC3R | P41968 | 1/20 | 0.37 |
| ▸ | MC1R | Q01726 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5123982 | 0.83 | P2RX7 (1.00) | P2RX7PTGDRHTR2CMCHR2MCHR1 | |
| Hydrochloric Acid SCHEMBL5128207 | 0.82 | P2RX7 (0.98) | P2RX7PTGDRHTR2CMCHR2MCHR1 | |
| SCHEMBL5128095 | 0.82 | P2RX7 (0.54) | P2RX7 | |
| SCHEMBL5128004 | 0.78 | P2RX7 (0.62) | P2RX7PTGDR | |
| SCHEMBL5131712 | 0.77 | P2RX7 (0.53) | P2RX7PTGDR | |
| SCHEMBL5125437 | 0.77 | P2RX7 (0.80) | P2RX7HTR2CMCHR2MCHR1 | |
| SCHEMBL27634467 | 0.77 | P2RX7 (0.80) | P2RX7HTR2CMCHR2MCHR1 | |
| Hydrochloric Acid SCHEMBL5131649 | 0.76 | P2RX7 (0.78) | P2RX7HTR2CMCHR2MCHR1 | |
| SCHEMBL5122845 | 0.76 | P2RX7 (0.53) | P2RX7 | |
| SCHEMBL5128753 | 0.75 | P2RX7 (0.54) | P2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009019503-A2 | P2X7 ANTAGONISTS FOR USE IN THE TREATMENT OF MOOD DISORDERS | ASTRAZENECA AB (SE) | 2009-02-12 | — | — | WO | disclosed |